Lv1
20 积分 2026-06-09 加入
Atopic dermatitis
2个月前
已完结
OP0186 EFFICACY AND SAFETY OF RILZABRUTINIB, AN ORAL BRUTON'S TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IgG4-RELATED DISEASE: RESULTS FROM A 52-WEEK, PHASE 2, OPEN-LABEL, PROOF-OF-CONCEPT STUDY
2个月前
已关闭
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
2个月前
已完结
Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF
3个月前
已完结
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
3个月前
已完结
皖公网安备34019202002308
